A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Anileridine
Bismuth subsalicylate
The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Antipyrine.
Anileridine
Olsalazine
The therapeutic efficacy of Olsalazine can be decreased when used in combination with Antipyrine.
Anileridine
Balsalazide
The therapeutic efficacy of Balsalazide can be decreased when used in combination with Antipyrine.
Anileridine
Dapoxetine
The risk or severity of gastrointestinal bleeding can be increased when Antipyrine is combined with Dapoxetine.
Anileridine
Indalpine
The risk or severity of gastrointestinal bleeding can be increased when Indalpine is combined with Antipyrine.
Anileridine
Zimelidine
The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Antipyrine.
Anileridine
Seproxetine
The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Antipyrine.
Anileridine
Levomilnacipran
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Antipyrine.
Anileridine
Desvenlafaxine
The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Antipyrine.
Anileridine
Milnacipran
The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Antipyrine.
Anileridine
Sibutramine
The risk or severity of gastrointestinal bleeding can be increased when Sibutramine is combined with Antipyrine.
Anileridine
Alaproclate
The risk or severity of gastrointestinal bleeding can be increased when Alaproclate is combined with Antipyrine.
Anileridine
Lithium cation
The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Antipyrine.
Anileridine
Hygromycin B
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Hygromycin B.
Anileridine
Dihydrostreptomycin
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Dihydrostreptomycin.
Anileridine
Puromycin
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Puromycin.
Anileridine
Neamine
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Neamine.
Anileridine
Apramycin
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Apramycin.
Anileridine
Geneticin
The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Geneticin.
Anileridine
Paromomycin
The risk or severity of nephrotoxicity can be increased when Paromomycin is combined with Antipyrine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3